|
IFT52 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.757400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.283800E-01 |
| Normal-vs-Stage2 |
1.745450E-01 |
| Normal-vs-Stage3 |
9.030100E-02 |
| Normal-vs-Stage4 |
4.915800E-01 |
| Stage1-vs-Stage2 |
6.260100E-02 |
| Stage1-vs-Stage3 |
1.188030E-02 |
| Stage1-vs-Stage4 |
2.513400E-01 |
| Stage2-vs-Stage3 |
8.426000E-01 |
| Stage2-vs-Stage4 |
5.153600E-01 |
| Stage3-vs-Stage4 |
3.322200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.665600E-01 |
| Normal-vs-AfricanAmerican |
1.029390E-01 |
| Normal-vs-Asian |
9.617600E-01 |
| Caucasian-vs-AfricanAmerican |
1.669960E-01 |
| Caucasian-vs-Asian |
8.752000E-01 |
| AfricanAmerican-vs-Asian |
4.703600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.774400E-01 |
| Normal-vs-Female |
2.407400E-01 |
| Male-vs-Female |
2.845600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.268400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.047800E-01 |
| Normal-vs-Age(61-80Yrs) |
5.621800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.475700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.319600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.920600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.075000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.848800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.170000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.336980E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.162200E-01 |
| Normal-vs-Grade 2 |
7.814400E-01 |
| Normal-vs-Grade 3 |
3.699800E-01 |
| Normal-vs-Grade 4 |
1.586240E-02 |
| Grade 1-vs-Grade 2 |
7.994200E-01 |
| Grade 1-vs-Grade 3 |
4.400400E-01 |
| Grade 1-vs-Grade 4 |
9.885600E-02 |
| Grade 2-vs-Grade 3 |
9.014100E-02 |
| Grade 2-vs-Grade 4 |
5.571300E-04 |
| Grade 3-vs-Grade 4 |
5.519600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.103000E-01 |
| Normal-vs-ccB subtype |
2.652800E-01 |
| ccA subtype-vs-ccB subtype |
7.773600E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.438200E-01 |
| Normal-vs-N1 |
1.650020E-01 |
| N0-vs-N1 |
2.696800E-01 |
|
|
